# FDA recall Z-1377-2021

> **Becton Dickinson & Co.** · Class II · device recall initiated 2021-03-17.

## Product

BD BBL Martin-Lewis Agar, 100 Ea - Product Usage: used for  the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi.  Catalog Number: 221558

## Reason for recall

Products show heavy growth of C. albicans after 24 hours of incubation due to misformulation (expected reaction is partial inhibition after 18-48 hours incubation)  and reduce the identification of Neisseria contributing to a delay in time to definitive diagnosis or a delay in proper treatment

## Distribution

Worldwide distribution - US Nationwide distribution and the countries of Canada, Korea.

## Key facts

- **Recall number:** Z-1377-2021
- **Recalling firm:** Becton Dickinson & Co.
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2021-03-17
- **Report date:** 2021-04-14
- **Termination date:** 2022-08-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sparks, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1377-2021

## Citation

> AI Analytics. FDA recall Z-1377-2021. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/Z-1377-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*